Cargando…
Peptide Targets to SARS-CoV-2
Autor principal: | Mandal, Santi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045537/ https://www.ncbi.nlm.nih.gov/pubmed/33888967 http://dx.doi.org/10.4103/jgid.jgid_208_20 |
Ejemplares similares
-
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020) -
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022) -
The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020) -
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection
por: Nolasco, Santi, et al.
Publicado: (2023) -
Apoptosis induced by SARS-CoV-2: can we target it?
por: Donia, Ahmed, et al.
Publicado: (2021)